perioperative management of glp 1 agonists Ozempic: Preoperative Patients on GLP-1 Receptor Glucagon-Like Peptide-1 Receptor Agonists in
Description
GLP-1 was identified as a potential incretin hormone [83]

H., and Yoo S

References Obesity and overweight [Online]

How long will it take to lose weight

The majority of these follow-on patents were filed between 2021 and 2022, coinciding with the launches of Mounjaro and Zepbound (Figure 10)

and spousal employment at Vertex Pharmaceuticals, all unrelated to the present work